Search
for
Sort by
Research 361–390 of 1000+
- Metabolic risk in PCOS: phenotype and adiposity impact
- An Update of Congenital Adrenal Hyperplasia
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Adult polycystic ovary syndrome begins in childhood
- Biochemical and trichological characterization of diffuse alopecia in women
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Frontal fibrosing alopecia: a survey in 16 patients
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- 9 Role of 5α-reductase in health and disease
- Androgens and androgen receptor action in skin and hair follicles
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Androgen excess is the key element in polycystic ovary syndrome
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Obesity and polycystic ovary syndrome
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss
- Diagnosis of hyperandrogenism: clinical criteria
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Safety of testosterone treatment in postmenopausal women
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Pathways to inflammation: acne pathophysiology
- Dermatology of androgen-related disorders